shiri keret Profile
shiri keret

@shirikeret

Followers
8
Following
8
Media
0
Statuses
7

Joined June 2023
Don't wanna be here? Send us removal request.
@docrota
Rohit Aggarwal
9 months
Dear Friends - Please join Myositis Clinical trial Consortium (MCTC) if you are interested in Myositis! Take a quick survey to be part of MCTC and collaborate in myositis studies ! We have 10 exciting global myositis project coming up in 2025 !
@MctcMyositis
MCTC myositis
10 months
4/5 Take a quick survey to share your expertise and learn how you can get involved in this important initiative. 📝➡️
2
17
30
@docrota
Rohit Aggarwal
1 year
What predicts poor outcomes of ILD in Myositis associated ILD? checkout Shiri’s poster at #ACR2024 which showed that higher age, Pulm HTN, decline in FVC and worsening dyspnea are predictors of 5 year mortality in ILD associated with myositis. https://t.co/gq2x2GZLhN
Tweet card summary image
acrabstracts.org
Background/Purpose: Lung involvement is the most common and severe extra-muscular manifestation of Idiopathic Inflammatory Myopathies (IIM). Early identification of patients at risk for lung transp...
1
8
32
@docrota
Rohit Aggarwal
1 year
Learn the importance of normal or low levels of CK in Myositis at #ACR2024 by Shiri Keret. Great study to highlight importance of low CK levels in Myositis is quite significant clinically.
Tweet card summary image
acrabstracts.org
Background/Purpose: Creatine kinase (CK) is an important biomarker for the diagnosis and monitoring of Idiopathic Inflammatory Myopathies (IIM). However, in some cases, CK levels might exhibit only...
0
19
56
@docrota
Rohit Aggarwal
1 year
Congratulations Shiri for teaching us about normal CK in Myositis at #ACR2024
2
6
77
@docrota
Rohit Aggarwal
1 year
Thanks Irada (#UPMC medicine resident) and Shiri (scientist from Israel) for #ACR2024 and presenting on predictors of ILD outcomes
0
1
15
@shirikeret
shiri keret
1 year
Grateful for this fruitful collaboration
@docrota
Rohit Aggarwal
1 year
Our Pittsburgh Myositis Center’s MAD (Myositis Accelerated Discovery) group at #ACR2024
0
0
1
@docrota
Rohit Aggarwal
1 year
My appeal to everyone interested in myositis to collaborate on the #Myositis Clinical Trial Consortium (MCTC)! 🌍 A global alliance advancing clinical trials in myositis & related ILD. 🤝 Learn more & join: https://t.co/JSPl7Xdfmz 📋 Membership form: https://t.co/FWnAQnowJZ
3
14
53